These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19442190)

  • 1. Kv7 channels as targets for the treatment of pain.
    Wickenden AD; McNaughton-Smith G
    Curr Pharm Des; 2009; 15(15):1773-98. PubMed ID: 19442190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic potential of neuronal KCNQ channel modulators.
    Gribkoff VK
    Expert Opin Ther Targets; 2003 Dec; 7(6):737-48. PubMed ID: 14640909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and behavioral signatures of Kv7 activator drug subtypes.
    Kanyo R; Wang CK; Locskai LF; Li J; Allison WT; Kurata HT
    Epilepsia; 2020 Aug; 61(8):1678-1690. PubMed ID: 32652600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural KCNQ (Kv7) channels.
    Brown DA; Passmore GM
    Br J Pharmacol; 2009 Apr; 156(8):1185-95. PubMed ID: 19298256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds.
    Xiong Q; Gao Z; Wang W; Li M
    Trends Pharmacol Sci; 2008 Feb; 29(2):99-107. PubMed ID: 18206251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kv7 Channels and Excitability Disorders.
    Jones F; Gamper N; Gao H
    Handb Exp Pharmacol; 2021; 267():185-230. PubMed ID: 33860384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand modulation of KCNQ-encoded (K
    Naffaa MM; Al-Ewaidat OA
    Eur J Pharmacol; 2021 Sep; 906():174278. PubMed ID: 34174270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Kv7 channels and excitability in the brain.
    Greene DL; Hoshi N
    Cell Mol Life Sci; 2017 Feb; 74(3):495-508. PubMed ID: 27645822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kv7 channels as targets for anti-epileptic and psychiatric drug-development.
    Grunnet M; Strøbæk D; Hougaard C; Christophersen P
    Eur J Pharmacol; 2014 Mar; 726():133-7. PubMed ID: 24457124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic potential of neuronal K V 7 (KCNQ) channel modulators: an update.
    Gribkoff VK
    Expert Opin Ther Targets; 2008 May; 12(5):565-81. PubMed ID: 18410240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kv7 (KCNQ) channel modulators and neuropathic pain.
    Munro G; Dalby-Brown W
    J Med Chem; 2007 May; 50(11):2576-82. PubMed ID: 17489574
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs.
    Miceli F; Soldovieri MV; Martire M; Taglialatela M
    Curr Opin Pharmacol; 2008 Feb; 8(1):65-74. PubMed ID: 18061539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCN and KV7 (M-) channels as targets for epilepsy treatment.
    Shah MM; Huang Z; Martinello K
    Neuropharmacology; 2013 Jun; 69():75-81. PubMed ID: 22446478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel treatment strategies for smooth muscle disorders: Targeting Kv7 potassium channels.
    Haick JM; Byron KL
    Pharmacol Ther; 2016 Sep; 165():14-25. PubMed ID: 27179745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels.
    Bentzen BH; Schmitt N; Calloe K; Dalby Brown W; Grunnet M; Olesen SP
    Neuropharmacology; 2006 Nov; 51(6):1068-77. PubMed ID: 16904708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Activation of Neuronal Voltage-Gated Kv7/KCNQ/M-Channels for Potential Therapy of Epilepsy and Pain.
    Liu Y; Bian X; Wang K
    Handb Exp Pharmacol; 2021; 267():231-251. PubMed ID: 33837465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K
    Bientinesi R; Mancuso C; Martire M; Bassi PF; Sacco E; Currò D
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):127-137. PubMed ID: 27761601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonreciprocal mechanisms in up- and downregulation of spinal motoneuron excitability by modulators of KCNQ/Kv7 channels.
    Lombardo J; Harrington MA
    J Neurophysiol; 2016 Nov; 116(5):2114-2124. PubMed ID: 27512022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kv7/KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release.
    Vervaeke K; Gu N; Agdestein C; Hu H; Storm JF
    J Physiol; 2006 Oct; 576(Pt 1):235-56. PubMed ID: 16840518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and motor functional roles of voltage-dependent type 7 K(+) channels in the human taenia coli.
    Adduci A; Martire M; Taglialatela M; Arena V; Rizzo G; Coco C; Currò D
    Eur J Pharmacol; 2013 Dec; 721(1-3):12-20. PubMed ID: 24120659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.